| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Comparative efficacy, work participation and time pointsWhat are the selected 12-month question and original subclaim verdict?Required |
The selected stored wording is maintained or restored work participation at 12 months, original grade B, with the note register-based adjusted difference +6.2 percentage points. The parent is B with 76 points. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Original wording, grade and note for maintained/restored work participation at 12 months |
Distinguish the original verdict from this production and review of existing content |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Comparative efficacy, work participation and time pointsDo maintained/restored and maintained/increased have the same definition?Required |
The subclaim's stored wording says maintained/restored, while the existing reader answer says maintained/increased work participation. This concerns actual work outcomes in national records. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Original classifications of baseline work status, maintenance, restoration and increase |
Distinguish original wording from the component results for maintenance, restoration and increase |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Comparative efficacy, work participation and time pointsAre the anxiety/depression population and high-risk exclusions distinguished?Required |
The parent's original outcome concerns 12-month work participation in adults with anxiety or depression. People at high suicide risk or with severe mental illness or active substance use were excluded. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Diagnosis, baseline work/benefit status, eligibility and exclusions |
Distinguish the recruited population from excluded high-risk groups |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Comparative efficacy, work participation and time pointsWhat combined service was the intervention?Required |
The evidence concerns a combined Norwegian service offering up to 15 sessions of work-focused CBT and individual job support. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Work-focused CBT, individual job support, delivery organization and study exposure |
Distinguish the combined program's identity from questions about individual components/other services |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Comparative efficacy, work participation and time pointsAre actual usual-care content and concomitant exposures by arm known?Required |
The comparison is 630 AWaC participants versus 563 receiving usual care. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Usual care, concomitant treatment, benefit/employment services and changes |
Distinguish the effect of assignment to the combined service from limitations of actual concomitant care |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Comparative efficacy, work participation and time pointsWhat are the original allocation unit, centers and denominators?Required |
This was a pragmatic multicenter randomized trial assigning 1,193 participants at six Norwegian centers, 630/563 by arm. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Centers, randomization process, allocation by arm and denominators |
Distinguish centers, allocated people and repeated-record units |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Comparative efficacy, work participation and time pointsWhat is the scope of the original evidence on allocation and outcome masking?Required |
The stored summary includes the allocation statement about an independent researcher without participant/center-staff contact and objective register-based ascertainment. Participant masking was impossible for psychotherapy. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Independent allocator, participant masking and register-based ascertainment |
Distinguish original methods descriptions from this summary-reading scope |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Comparative efficacy, work participation and time pointsWhich records established work participation?Required |
Monthly work and benefit status were determined from Norwegian national insurance and employment registers. These are actual outcomes distinct from questionnaire scores. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
National insurance/employment registers and monthly work/benefit-status definitions |
Distinguish actual work outcomes from questionnaires and other functional outcomes |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Comparative efficacy, work participation and time pointsWhat is the scope of zero loss to follow-up at 12 months?Required |
The original material states that 12-month results were obtained for all 1,193 participants and primary-outcome loss to follow-up was 0/1,193. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Primary outcome, register-data acquisition/linkage and missing data by arm |
Separate complete primary-outcome follow-up from denominators for other materials/time points |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Comparative efficacy, work participation and time pointsAre original arm-specific proportions and the unadjusted difference preserved?Required |
Maintained/increased participation at 12 months was 44.2% versus 37.2%, unadjusted difference 6.9 percentage points, P=.015. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
44.2/37.2 and the directly reported unadjusted difference/P |
Display rounded proportions separately from the directly reported difference |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Comparative efficacy, work participation and time pointsWhat is the prespecified covariate-adjusted marginal effect?Required |
The described prespecified covariate-adjusted marginal effect is +6.2 percentage points, 95% CI +0.5~+11.8. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Adjusted estimate, CI, covariates and effect of interest |
Separate original proportions, unadjusted and adjusted effects |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Comparative efficacy, work participation and time pointsDoes the analysis answer assignment, actual participation or completers?Required |
The existing evidence list supplies a 12-month comparison of the originally randomized 1,193 participants with complete register follow-up. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Analysis population, effect of interest, concomitant exposures and imputation/exclusions |
Distinguish assignment comparisons from adherence/completer effects |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Comparative efficacy, work participation and time pointsAre low session attendance and work-outcome follow-up distinguished?Required |
Preserve the Korean safety statement describing 5% of AWaC participants stopping treatment before three sessions and the English original describing attendance at fewer than three sessions. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Treatment attendance, discontinuation, reasons/timing and register follow-up |
Distinguish treatment participation from primary work-outcome follow-up |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Comparative efficacy, work participation and time pointsWere the 12-month primary outcome, prespecified adjustment and planning material actually read?Required |
The original summary describes agreement of the objective 12-month work-participation primary outcome with NCT01146730 and prespecified adjustment. A registration citation link is also present. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
NCT, primary outcome, prespecified models, protocol, SAP and history |
Distinguish preserved prespecified-planning descriptions from actual external reading |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Comparative efficacy, work participation and time pointsHas clinical/work importance of maintenance/restoration been newly defined?Required |
Original proportions and effects directly concern work participation at 12 months. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Prespecified importance, working hours, job satisfaction, income and functional criteria |
Distinguish statistical comparisons from gaps in importance and other outcomes |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Comparative efficacy, work participation and time pointsHas the 18-month observation been transferred into 12-month or long-term effects?Required |
The original product information also records an 18-month observed difference of +7.8 percentage points, P=.018. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Comparisons, denominators, observation and analysis by time point |
Display 12/18-month and long-term extension results separately |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Comparative efficacy, work participation and time pointsHas a favorable short-term result filled in the null full-cohort result at 10~46 months?Required |
The same-cohort 10~46-month extension records no significant full-cohort differences in income, work participation or months without benefits. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Direct long-term full-cohort effects and denominators by outcome |
Distinguish favorable short-term from null long-term results |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Comparative efficacy, work participation and time pointsHas the signal in long-term benefit recipients been expanded to the full cohort?Required |
The long-term extension summary states significance only in the long-term-benefit subgroup. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Subgroup definition, plans, denominators, effects and interactions |
Display full-cohort and subgroup direct results separately |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Comparative efficacy, work participation and time pointsAre same-cohort long-term reports, registration and the two sheets independent replication?Required |
The main AWaC report, long-term report and registration concern the same trial; both selected questions share the stored verdict 2954 summary. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Linkage of original trial, extension, registration, participants and time points |
Separate citation entries from actual trial/participant units |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Comparative efficacy, work participation and time pointsHas complete 12-month follow-up been reused as the long-term analysis denominator?Required |
Acquisition of outcomes for all 1,193 participants and zero loss are original statements about the 12-month primary outcome. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Measured, analyzed, linked and lost denominators at 10~46 months |
Separate actual observation/analysis scope by time point |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Comparative efficacy, work participation and time pointsHave different delivery systems/vocational-advice verdicts been merged as the same effect?Required |
The existing advertising interpretation says AWaC differs in delivery system/population from physiotherapist vocational advice in verdict 2944, B with 72 points. The related path is preserved in the summary. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Actual comparisons of the combined service, populations and delivery systems |
Preserve only the original related context and distinguish service-specific questions |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Comparative efficacy, work participation and time pointsAre public funding, center operation and evaluator roles distinguished?Required |
The Korean summary records full funding by the Health and Labour Ministries through the National Strategy on Work and Mental Health, NAV center operation, and independent evaluators uninvolved in center operation/treatment. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Health/Labour Ministries, NAV and evaluator roles/authority |
Display public support, service operation and evaluator roles separately |
| 23 |
Unverified |
Full text not readStored summary read |
N23 · Comparative efficacy, work participation and time pointsAre complete disclosures of author, analysis, writing and publication support available?Required |
The stored summary describes public funding, NAV operation and evaluation independence. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Author relationships, analysis, medical writing, publication and data/publication authority |
Distinguish known roles from unverified complete disclosures |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Supplementary harm evidenceWere prespecified safety outcomes or serious-adverse-event tables reported?Supplementary |
The existing safety explanation states no prespecified safety outcome or serious-adverse-event comparison table was reported. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Harm plans, definitions, collection, arm-specific events and denominators |
Distinguish acquisition of work records from safety-data collection |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Supplementary harm evidenceCan high-risk exclusions and 5% low attendance certify harms?Supplementary |
Original information excludes high suicide risk, severe mental illness and active substance use, and describes 5% of AWaC participants stopping before three treatment sessions. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
High-risk groups, discontinuation reasons, events, causes and follow-up |
Distinguish intervention participation from harms and applicability limits |
| 26 |
Unverified |
Full text not readStored summary read |
N26 · Supplementary harm evidenceDo long-term/rare harms and clinical symptoms require separate evidence?Supplementary |
Original safety is Unknown; primary work outcomes and the long-term work extension are separate. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Long-term exposure, events, symptoms, function and follow-up denominators |
Separate work participation from gaps in clinical/safety outcomes |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Comparative efficacy, work participation and time pointsIs actual summary reading distinguished from unread external papers/registration?Required |
The complete parent stored summary was read. Main/long-term PubMed URLs and the official registration URL are linked as original citations. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Each citation, original registration URL, preservation and access status |
Display summary reading separately from unread external material by type |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Comparative efficacy, work participation and time pointsAre original history/selected-verdict linkage separated from production and content review?Required |
Preserve parent Korean/English text, axes, reference date 2026-08-26, empty corrections/deliberation and the selected row within the whole stored summary. Original candidate review-pending/production-eligibility flags are historical. |
Stored-summary information, scope and gaps displayed; not completed content review or a new clinical verdict |
Parent Korean/English text, axes, dates, corrections, selected row and freezing/application |
Record original verdicts/corrections separately from production and review of existing content |